CACLP - The largest IVD Expo & Conference

Roche Receives FDA Emergency Use Authorization for Cobas Monkeypox Test

Industry news | 16 November, 2022 | CACLP

Original from: Genomeweb


The US Food and Drug Administration said on Tuesday that it has granted Emergency Use Authorization for Roche's molecular monkeypox test. 


The RT-PCR test, which qualitatively detects DNA from monkeypox virus in human lesion swab specimens, runs on the Cobas 6800/8800 systems. It is intended for use at moderate- and high-complexity labs and authorized for use in people suspected of monkeypox virus infection by their healthcare provider, the FDA said in a statement. 


The agency began issuing EUAs for monkeypox tests in September after the US Department of Health and Human Services declared a public health emergency for the virus in August. Quest Diagnostics obtained EUA for its monkeypox test in September, while Abbott received EUA for its test last month. 


Source: Roche Receives FDA Emergency Use Authorization for Cobas Monkeypox Test

Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference